Cargando…

Assessing the Effectiveness of Type 2 Diabetes Screening in the Republic of Uzbekistan

BACKGROUND: Type 2 diabetes (T2D) screening should be performed continuously at the primary care level in order to prevent disabling complications. Due to the high prevalence of undiagnosed T2D in the Republic of Uzbekistan, a decision was made to implement a nationwide screening program for T2D. OB...

Descripción completa

Detalles Bibliográficos
Autores principales: Alieva, Anna, Alimov, Anvar, Khaidarova, Feruza, Ismailov, Saidiganikhoja, Rakhimova, Gulnara, Nazhmutdinova, Dilorom, Shagazatova, Barno, Tsareva, Victoria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Brieflands 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9871961/
https://www.ncbi.nlm.nih.gov/pubmed/36714191
http://dx.doi.org/10.5812/ijem-124036
_version_ 1784877298331156480
author Alieva, Anna
Alimov, Anvar
Khaidarova, Feruza
Ismailov, Saidiganikhoja
Rakhimova, Gulnara
Nazhmutdinova, Dilorom
Shagazatova, Barno
Tsareva, Victoria
author_facet Alieva, Anna
Alimov, Anvar
Khaidarova, Feruza
Ismailov, Saidiganikhoja
Rakhimova, Gulnara
Nazhmutdinova, Dilorom
Shagazatova, Barno
Tsareva, Victoria
author_sort Alieva, Anna
collection PubMed
description BACKGROUND: Type 2 diabetes (T2D) screening should be performed continuously at the primary care level in order to prevent disabling complications. Due to the high prevalence of undiagnosed T2D in the Republic of Uzbekistan, a decision was made to implement a nationwide screening program for T2D. OBJECTIVES: The current study, taking into account the limited resources of Uzbekistan's health care system, aimed to offer the most effective, simple, and economical option required for the actual implementation of regular T2D screening in the country’s primary care. METHODS: The screening was conducted from December 2018 to March 2019. There were four different scenarios, which differed in terms of eligibility criteria and the methodology adopted for detecting dysglycemia. RESULTS: A total of 2,430 patients were examined in four months. The T2D diagnosis was established by an endocrinologist in 9.3% of the cases with one eligibility criterion and 15.9% of the cases with three eligibility criteria. The diagnosis of T2D was established by an endocrinologist in 11.7% of the cases with HbA1c screening and 13.5% of the cases with glucose screening. CONCLUSIONS: The screening was feasible in Uzbekistan only in limited conditions. The reasonable strategy was found to be the screening for incidental glycemia in all patients with at least one T2D risk factor. It was recommended that patients with incidental glycemia ≥ 7.8 mmol/L should be tested for fasting glycemia.
format Online
Article
Text
id pubmed-9871961
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Brieflands
record_format MEDLINE/PubMed
spelling pubmed-98719612023-01-28 Assessing the Effectiveness of Type 2 Diabetes Screening in the Republic of Uzbekistan Alieva, Anna Alimov, Anvar Khaidarova, Feruza Ismailov, Saidiganikhoja Rakhimova, Gulnara Nazhmutdinova, Dilorom Shagazatova, Barno Tsareva, Victoria Int J Endocrinol Metab Research Article BACKGROUND: Type 2 diabetes (T2D) screening should be performed continuously at the primary care level in order to prevent disabling complications. Due to the high prevalence of undiagnosed T2D in the Republic of Uzbekistan, a decision was made to implement a nationwide screening program for T2D. OBJECTIVES: The current study, taking into account the limited resources of Uzbekistan's health care system, aimed to offer the most effective, simple, and economical option required for the actual implementation of regular T2D screening in the country’s primary care. METHODS: The screening was conducted from December 2018 to March 2019. There were four different scenarios, which differed in terms of eligibility criteria and the methodology adopted for detecting dysglycemia. RESULTS: A total of 2,430 patients were examined in four months. The T2D diagnosis was established by an endocrinologist in 9.3% of the cases with one eligibility criterion and 15.9% of the cases with three eligibility criteria. The diagnosis of T2D was established by an endocrinologist in 11.7% of the cases with HbA1c screening and 13.5% of the cases with glucose screening. CONCLUSIONS: The screening was feasible in Uzbekistan only in limited conditions. The reasonable strategy was found to be the screening for incidental glycemia in all patients with at least one T2D risk factor. It was recommended that patients with incidental glycemia ≥ 7.8 mmol/L should be tested for fasting glycemia. Brieflands 2022-11-01 /pmc/articles/PMC9871961/ /pubmed/36714191 http://dx.doi.org/10.5812/ijem-124036 Text en Copyright © 2022, International Journal of Endocrinology and Metabolism https://creativecommons.org/licenses/by-nc/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
spellingShingle Research Article
Alieva, Anna
Alimov, Anvar
Khaidarova, Feruza
Ismailov, Saidiganikhoja
Rakhimova, Gulnara
Nazhmutdinova, Dilorom
Shagazatova, Barno
Tsareva, Victoria
Assessing the Effectiveness of Type 2 Diabetes Screening in the Republic of Uzbekistan
title Assessing the Effectiveness of Type 2 Diabetes Screening in the Republic of Uzbekistan
title_full Assessing the Effectiveness of Type 2 Diabetes Screening in the Republic of Uzbekistan
title_fullStr Assessing the Effectiveness of Type 2 Diabetes Screening in the Republic of Uzbekistan
title_full_unstemmed Assessing the Effectiveness of Type 2 Diabetes Screening in the Republic of Uzbekistan
title_short Assessing the Effectiveness of Type 2 Diabetes Screening in the Republic of Uzbekistan
title_sort assessing the effectiveness of type 2 diabetes screening in the republic of uzbekistan
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9871961/
https://www.ncbi.nlm.nih.gov/pubmed/36714191
http://dx.doi.org/10.5812/ijem-124036
work_keys_str_mv AT alievaanna assessingtheeffectivenessoftype2diabetesscreeningintherepublicofuzbekistan
AT alimovanvar assessingtheeffectivenessoftype2diabetesscreeningintherepublicofuzbekistan
AT khaidarovaferuza assessingtheeffectivenessoftype2diabetesscreeningintherepublicofuzbekistan
AT ismailovsaidiganikhoja assessingtheeffectivenessoftype2diabetesscreeningintherepublicofuzbekistan
AT rakhimovagulnara assessingtheeffectivenessoftype2diabetesscreeningintherepublicofuzbekistan
AT nazhmutdinovadilorom assessingtheeffectivenessoftype2diabetesscreeningintherepublicofuzbekistan
AT shagazatovabarno assessingtheeffectivenessoftype2diabetesscreeningintherepublicofuzbekistan
AT tsarevavictoria assessingtheeffectivenessoftype2diabetesscreeningintherepublicofuzbekistan